Year: 2021

BEVERLY, Mass., Nov. 24, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, today announced it intends to pursue both 510k clearance and CLIA-waiver from the FDA to utilize the full potential of the MiQLab System™ for syndromic testing at the point of care. Syndromic testing allows medical providers to simultaneously test patient specimens for multiple pathogens that produce overlapping signs and symptoms. MiQLab’s broad multiplexing provides this capability and also allows for testing other clinically important markers such as antimicrobial resistance genes. Antimicrobial resistance is widely considered to be the next global pandemic.1 Scientists estimate that drug resistant...

Company AnnouncementHørsholm, Denmark (November 24, 2021) — Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that the Board of Directors of Allarity has exercised the authorization granted by the shareholders at the Extraordinary General Meeting held on November 22, 2021, to issue new warrants. The Board has resolved to grant a total of 51,292,653 warrants as a part of a new incentive program for the Board of Directors, employees and consultants in Allarity. All warrants are issued free of charge and are issued to ensure alignment of interests between the Company’s employees, management, Board of Directors, and shareholders as the Company completes its recapitalization, restructuring, and migration to the U.S. Nasdaq stock market. The 51,292,653 warrants to employees, consultants and board...

Company’s First In-license Pipeline Product to Enter Pre-clinical Studies Boca Raton, FL, Nov. 24, 2021 (GLOBE NEWSWIRE) — Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today the company has advanced into ocular tolerance evaluation of various metformin eye drop formulations.  As a significant step towards moving into human clinical trials, the current studies focus on tolerability and pharmacokinetics which will assess the ocular tissue distribution after topical ocular delivery of metformin. These studies will aid in optimization of the formulation and build evidence to ensure adequate exposure and safety via topical ocular delivery, which will support the company to move into Good Laboratory...

Press releaseParis, 24 November 2021 Communiqué from the Board of Directors of Orange Following the verdict reached by the Paris Appeal Court, the Orange group’s Board of Directors met today and took note of Stéphane Richard’s decision to hand over his mandate as Chairman and CEO. The Board has accepted his resignation. This will take effect once the new governance structure has been appointed and at the latest by 31 January 2022. Stéphane Richard will continue in his role until this date. The Board of Directors wishes to underline Stéphane Richard’s desire to ensure that the Group’s governance is preserved. The Board thanks him for his commitment at the helm of Orange for the past 11 years, from restoring an appeased working environment after the social crisis to the transformation of Orange into a leading multi-service operator...

Ten new members drawn from Canada’s First Nations, Inuit and Métis communities join Council The Council will provide advice and guidance to the board and CEO of CN on deepening its relationship with Indigenous peoples MONTREAL, Nov. 24, 2021 (GLOBE NEWSWIRE) — The co-chairs of CN’s (TSX: CNR) (NYSE: CNI) new Indigenous Advisory Council (“IAC”), Ms. Roberta Louise Jamieson, OC, Kanyen’kehà:ka, and the Hon. Murray Sinclair, C.C., M.S.M., Mizhana Geezhik, today announced the successful conclusion of their first meeting and its membership. The Council comprises accomplished and respected representatives of Canada’s First Nations, Inuit and Métis communities who will provide advice to CN’s Board and to the company’s President and Chief Executive Officer on issues that are relevant to CN’s relationship with the more than 200 Indigenous...

Singapore, Nov. 24, 2021 (GLOBE NEWSWIRE) —  8i Acquisition 2 Corp. (NASDAQ: LAXXU) (the “Company”), a newly organized blank check company incorporated as a British Virgin Islands business company and led by Chief Executive Officer, Meng Dong (James) Tan, today announced that it closed its initial public offering of 8,625,000 units at an offering price of $10.00 per unit, which includes 1,125,000 units issued pursuant to the full exercise of the underwriter’s over-allotment option, for aggregate gross proceeds to the Company of $86,250,000. The units began trading on the NASDAQ Global Market (“NASDAQ”) under the ticker symbol “LAXXU” on November 22, 2021. Each unit consists of one ordinary share, one warrant to purchase one-half (1/2) of one ordinary share, and one right to receive one-tenth (1/10) of an ordinary share upon the...

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (ASX: MIO) (TSX-V: MMS) (OTCQB: MMSDF) (the Company or Macarthur) is pleased to announce that the Initial Public Offering (IPO) of its spin-out company, Infinity Mining Limited (Infinity) has now closed. The IPO offer opened on 5 November 2021 and closed oversubscribed on 19 November 2021 under its Prospectus dated 28 October 2021.Key points Under the offer, the Company intended to raise between $7 million and $10 million with the offer closing oversubscribed at its targeted maximum subscription of $10 millionInfinity is on track to complete its Initial Public Offering (IPO) and list on the Australian Securities Exchange (ASX)Reserved ASX ticker code IMIInfinity, a spin-out of Macarthur’s non-iron assets will fast track further...

HUNTINGTON BEACH, CA, Nov. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — One World Universe Inc. (OTC: OWUV), a publicly traded company that invests in sports related businesses, distressed assets, business opportunities within emerging industries and providing humanitarian efforts in over 185 countries, is proud to be a part of the upcoming MVP Movie.  “As the NFL season is in full swing, our first investment in Nate Boyer and his MVP movie is gaining attention. The NFL recently had a segment highlighting the charitable MVP organization, which stands for Merging Vets and Players, and was the inspiration for the actual movie.  I am excited to work with Nate on this project. It is an honor to be a part of a project that helps our military brother and sisters but also bold enough to tackle the sensitive issue of mental health,...

CHEO Dream Room PhotoBook a CHEO Dream Room at any Marriott branded hotel on December 11, 2021 and 100% of the room revenue will be donated to the Children’s Hospital of Eastern Ontario (CHEO).OTTAWA, Nov. 24, 2021 (GLOBE NEWSWIRE) — Book a CHEO Dream Room at any Marriott branded hotel on December 11, 2021 and 100% of the room revenue will be donated to the Children’s Hospital of Eastern Ontario (CHEO). “What a chance for our guests to enjoy a special holiday hotel stay and at the same time know that all the room revenue is going to support a great cause. Perhaps it is time for a date night or a shopping spree and dinner out?” said Ross Meredith, GM of both The Westin Ottawa and Delta Hotels by Marriott Ottawa City Center. “Marriott hotels have been fundraising for CHEO for over 20 years and have raised close...